461 related articles for article (PubMed ID: 24966582)
1. Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.
Lonardo A; Adinolfi LE; Restivo L; Ballestri S; Romagnoli D; Baldelli E; Nascimbeni F; Loria P
World J Gastroenterol; 2014 Jun; 20(23):7089-103. PubMed ID: 24966582
[TBL] [Abstract][Full Text] [Related]
2. Metabolic alterations and hepatitis C: From bench to bedside.
Chang ML
World J Gastroenterol; 2016 Jan; 22(4):1461-76. PubMed ID: 26819514
[TBL] [Abstract][Full Text] [Related]
3. Genotype 3 Infection: The Last Stand of Hepatitis C Virus.
Chan A; Patel K; Naggie S
Drugs; 2017 Feb; 77(2):131-144. PubMed ID: 28074358
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Hwang SJ; Lee SD
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
[TBL] [Abstract][Full Text] [Related]
5. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
Ryan MC; Desmond PV; Slavin JL; Congiu M
J Viral Hepat; 2011 Jan; 18(1):53-60. PubMed ID: 20196803
[TBL] [Abstract][Full Text] [Related]
6. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
Lonardo A; Loria P; Adinolfi LE; Andreana A; Ruggiero G; Carulli N
Ann Ital Med Int; 2005; 20(1):10-22. PubMed ID: 15859390
[TBL] [Abstract][Full Text] [Related]
7. The Effect of HCV Eradication after Direct-Acting Antiviral Agents on Hepatic Steatosis: A Prospective Observational Study.
Soliman H; Ziada D; Hamisa M; Badawi R; Hawash N; Salama M; Abd-Elsalam S
Endocr Metab Immune Disord Drug Targets; 2022; 22(1):100-107. PubMed ID: 33550979
[TBL] [Abstract][Full Text] [Related]
8. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus diversity and hepatic steatosis.
Roingeard P
J Viral Hepat; 2013 Feb; 20(2):77-84. PubMed ID: 23301542
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of steatosis in hepatitis C virus infection.
Adinolfi LE; Restivo L; Marrone A
Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):205-13. PubMed ID: 23445230
[TBL] [Abstract][Full Text] [Related]
11. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations.
Adinolfi LE; Rinaldi L; Guerrera B; Restivo L; Marrone A; Giordano M; Zampino R
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231906
[TBL] [Abstract][Full Text] [Related]
12. Small heterodimer partner 1 directly interacts with NS5A viral protein and has a key role in HCV related liver cell transformation.
Conti B; Porcu C; Viscomi C; Minutolo A; Costantini S; Corazzari M; Iannucci G; Barbaro B; Balsano C
Oncotarget; 2016 Dec; 7(51):84575-84586. PubMed ID: 27661118
[TBL] [Abstract][Full Text] [Related]
13. Lipid metabolism and liver disease in hepatitis C viral infection.
Koike K; Tsutsumi T; Yotsuyanagi H; Moriya K
Oncology; 2010 Jul; 78 Suppl 1():24-30. PubMed ID: 20616580
[TBL] [Abstract][Full Text] [Related]
14. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.
Patra T; Sasaki R; Meyer K; Ray RB; Ray R
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135
[TBL] [Abstract][Full Text] [Related]
15. Animal models in the study of hepatitis C virus-associated liver pathologies.
Lerat H; Higgs M; Pawlotsky JM
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):341-52. PubMed ID: 21651352
[TBL] [Abstract][Full Text] [Related]
16. Impact of HCV genetic differences on pathobiology of disease.
Ripoli M; Pazienza V
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):747-59. PubMed ID: 21905784
[TBL] [Abstract][Full Text] [Related]
17. [Steatosis and hepatitis C].
Testino G
Recenti Prog Med; 2005 Dec; 96(12):621-33; quiz 654. PubMed ID: 16496750
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection and liver steatosis.
Ramalho F
Antiviral Res; 2003 Oct; 60(2):125-7. PubMed ID: 14638408
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.
Rockey DC; Friedman SL
Gastroenterology; 2021 Apr; 160(5):1502-1520.e1. PubMed ID: 33529675
[TBL] [Abstract][Full Text] [Related]
20. Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis.
Kawagishi N; Suda G; Nakamura A; Kimura M; Maehara O; Suzuki K; Nakamura A; Ohara M; Izumi T; Umemura M; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Kudo Y; Nishida M; Miyoshi H; Sakamoto N
PLoS One; 2018; 13(12):e0209615. PubMed ID: 30576386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]